Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
Clinical trial NCT06326021 · RECRUITING
Trial details
- NCT number
- NCT06326021
- Sponsor
- Beijing GoBroad Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2026-06-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.